Dl-Penicillamine

Dl-Penicillamine

SCHEMBL5237609

CC(C)(S)[C@H](N)C(=O)O.CNCC(=O)O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
MAPT P10636 2/20 0.67
PTGS1 P23219 2/20 0.67
LMNA P02545 1/20 0.33
PTGS2 P35354 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
BHMT Q93088 3/20 0.32
SLC7A11 Q9UPY5 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dl-Penicillamine SCHEMBL27615310 1.00 ALDH1A1 (0.67) ALDH1A1MAPTPTGS1LMNAPTGS2
Penicillamine SCHEMBL603349 0.82 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1LMNATDP1
Penicillamine SCHEMBL4343 0.82
Dl-Penicillamine SCHEMBL22322162 0.82 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1LMNATDP1
Penicillamine SCHEMBL129296 0.82 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1LMNATDP1
Dl-Penicillamine SCHEMBL57527 0.82
Dl-Penicillamine SCHEMBL159653 0.82 ALDH1A1 (1.00) ALDH1A1MAPTPTGS1LMNATDP1
Dl-Penicillamine SCHEMBL4344 0.82
Penicillamine SCHEMBL2329725 0.80 ALDH1A1 (0.78) ALDH1A1MAPTPTGS1LMNASLC7A11
Dl-Penicillamine SCHEMBL2319399 0.80 ALDH1A1 (0.78) ALDH1A1MAPTPTGS1LMNASLC7A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799683-A1 HEXAHYDRO-PYRAZINO[1,2-A]PYRIMIDINE-4, 7-DIONE DERIVATIVES SUBSTITUTED WITH AMINO ACIDS Sanofi-Aventis Deutschland GmbH (DE) 2007-06-27 EP disclosed
WO-2006024390-A1 HEXAHYDRO-PYRAZINO[1,2-A]PYRIMIDINE-4, 7-DIONE DERIVATIVES SUBSTITUTED WITH AMINO ACIDS SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2006-03-09 WO disclosed
EP-1420826-A2 COMBINATION PREPARATIONS OF ARYL SUBSTITUTED PROPANOLAMINE DERIVATIVES WITH OTHER ACTIVE INGREDIENTS AND THE USE THEREOF Aventis Pharma Deutschland GmbH (DE) 2004-05-26 EP disclosed
WO-2003018059-A2 COMBINATION PREPARATIONS OF ARYL SUBSTITUTED PROPANOLAMINE DERIVATIVES WITH OTHER ACTIVE INGREDIENTS AND THE USE THEREOF AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-03-06 WO disclosed
EP-1117645-A1 ARYL-SUBSTITUTED PROPANOLAMINE DERIVATIVES, METHODS FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND THEIR USE Aventis Pharma Deutschland GmbH (DE) 2001-07-25 EP disclosed
EP-1117676-A1 PROPANOLAMINE DERIVATIVES LINKED WITH BILE ACID USED FOR TREATING DISORDERS OF THE LIPID METABOLISM Aventis Pharma Deutschland GmbH (DE) 2001-07-25 EP disclosed
WO-2000020437-A1 PROPANOLAMINE DERIVATIVES LINKED WITH BILE ACID USED FOR TREATING DISORDERS OF THE LIPID METABOLISM AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-04-13 WO disclosed
WO-2000020392-A1 ARYL-SUBSTITUTED PROPANOLAMINE DERIVATIVES, METHODS FOR THEIR PRODUCTION, MEDICAMENTS CONTAINING SAID COMPOUNDS AND THEIR USE AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-04-13 WO disclosed